Sugeiry Lourdes Vernacchio, LPN | |
8 Banta Pl, Bergenfield, NJ 07621-1104 | |
(201) 665-7532 | |
Not Available |
Full Name | Sugeiry Lourdes Vernacchio |
---|---|
Gender | Female |
Speciality | Licensed Practical Nurse |
Location | 8 Banta Pl, Bergenfield, New Jersey |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1134716772 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
164W00000X | Licensed Practical Nurse | 26NP07721300 (New Jersey) | Primary |
Mailing Address | Practice Location Address |
---|---|
Sugeiry Lourdes Vernacchio, LPN 8 Banta Pl, Bergenfield, NJ 07621-1104 Ph: (201) 665-7532 | Sugeiry Lourdes Vernacchio, LPN 8 Banta Pl, Bergenfield, NJ 07621-1104 Ph: (201) 665-7532 |
News Archive
The Lupus Foundation of America has launched a new nationwide education series, Lupus: Learn from the Experts, designed to provide people with lupus essential information about living with lupus from some of the world's leading lupus experts. The program is a series of teleconferences hosted by a lupus expert, and will cover a wide variety of topics important to people with lupus, including disability, kidney involvement, and clinical trials.
Scientists have identified the key molecular pathway leading to depression, revealing potential new targets for drug discovery, according to research led by King's College London's Institute of Psychiatry. The study, published today in Neuropsychopharmacology, reveals for the first time that the 'Hedgehog pathway' regulates how stress hormones, usually elevated during depression, reduce the number of brain cells.
A new review is the first to directly examine the role of various stem cells in the healing of wounded cornea, the outermost part of the eye. In contrast with most other reviews, it covers all major corneal cell types in a comprehensive way, showing similarities and differences in the healing process and the usage of stem cells for therapy.
The Norwegian biopharmaceutical company Lytix Biopharma and Korean company KAEL-GemVax today announced approval by the Norwegian Medicines Agency ('Statens Legemiddelverk') to test a combination of LTX-315 and GV1001 as vaccine therapy in patients with resected tumours. Lytix Biopharma CEO Gunnar Salid states, "We are delighted to announce the approval of our joint study to test a combination of two very interesting experimental drugs.
1386 of the cases were due to the potentially fatal Plasmodium falciparum which is a major international health risk and which kills more than a million people a year in Africa. 219 were due to Plasmodium vivax which causes a debilitating disease, but is rarely fatal.
› Verified 2 days ago
Mr. Nelson C Virtusio, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 11 Carlisle St, Bergenfield, NJ 07621 Phone: 201-888-4750 | |
Mary Friedrich, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 4 Sergent Ct, Bergenfield, NJ 07621 Phone: 718-828-2666 | |
Frezhia Kate L Vergara, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 406 S Washington Ave, Bergenfield, NJ 07621 Phone: 201-384-4447 | |
Ms. Jacquelynn Dorthea Coviel, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 406 S Washington Ave, Bergenfield, NJ 07621 Phone: 201-384-4447 | |
Mr. Carlo M Guce, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 90 N Queen St, Bergenfield, NJ 07621 Phone: 201-214-2512 | |
Tiffany Lee Pizarro, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 60 Howard Dr Apt M, Bergenfield, NJ 07621 Phone: 347-503-8865 |